Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist.
Nefrologia (Engl Ed)
; 43(4): 399-412, 2023.
Article
de En
| MEDLINE
| ID: mdl-37813741
Mots clés
Agonistas del receptor del péptidosimilar al glucagón tipo 1 GLP-1; Cardioprotección; Cardioprotection; Diabetes mellitus tipo 2; Diabetic kidney disease; Enfermedad renal diabética; Glucagon-like peptide 1 GLP-1 receptor agonists; Nefroprotección; Nephroprotection; Oral semaglutide; Semaglutida oral; Type 2 diabetes mellitus
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Diabète de type 2
/
Insuffisance rénale chronique
Type d'étude:
Risk_factors_studies
Limites:
Humans
Langue:
En
Journal:
Nefrologia (Engl Ed)
Année:
2023
Type de document:
Article
Pays de publication:
Espagne